Antenatal Hormone Therapy for Improving the Outcome of the Preterm Infant

Journal of Perinatology

Volumn 16, Issue 5, 1996, Pages 390-396

  Ballard, Roberta A ^a,b   Ballard, Philip L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HORMONE;

FEMALE; FETUS DISEASE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRENATAL CARE; PROGNOSIS; REVIEW;

ADRENAL CORTEX HORMONES; FEMALE; FETAL DISEASES; HORMONES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROGNOSIS;

EID: 0030228783     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fanaroff AA, Wright LL, Stevenson DK, et al. Very-low-birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 to December 1992. Am J Obstet Gynecol 1995;173:1423-31.
2. Buckingham S, McNary WF, Sommers SC, et al. Is lung an analog of Moog's developing intestine? I. Phosphatases and pulmonary alveolar differentiation in fetal rabbits. Fed Proc 1968;27:328.
3. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969;45:515-23.
4. Ballard PL. Hormones and lung maturation. Monographs on Endocrinology, vol. 28. Berlin: Springer-Verlag, 1986.
5. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-62.
6. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-20.
7. Crowley P. Update of the antenatal steroid meta-analysis: current knowledge and future research needs. Am J Obstet Gynecol 1995;173: 322-35.
8. Sinclair JC. Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. Bethesda, Maryland: National Institutes of Health, November 1994; NIH publication no. 95-3784, p. 95.
9. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981;141:276-86.
10. Ohlsson A. Treatment of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890-906.
11. 2. J Pediatr 1981;98:126-8.
12. Clyman RI, Ballard PL, Sniderman S, et al. Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 1981;98:123-6.
13. Waffarn F, Siassi B, Cabal LA, Schmidt PL. Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus. Am J Dis Child 1983;137:336-8.
14. Papageorgiou AN, Doray JL, Ardilia R. Reduction of mortality, morbidity and respiratory distress syndrome in infants weighing less than 1,000 grams by treatment with betamethasone and ritodrine. Pediatrics 1989; 83:493-7.
15. Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. Am J Dis Child 1993;147:187-92.
16. Moog F. Developmental adaptations of alkaline phosphatases in the small intestine. Fed Proc 1962;21:51.
17. Bauer CR, Morrison JC, Poole WK, et al. Decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984;73:682-8.
18. Halac E, Halac J, Beque EF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990;117:132-8.
19. Barks JD, Post M, Tuor UI. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 1991;29:558-63.
20. Clark CE, Clyman RI, Ballard RA. Risk factor analysis of intraventricular hemorrhage in low-birth-weight infants. J Pediatr 1981;99:625-8.
21. Leviton A, Kuban KC, Pagano M, Alfred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 1993; 91:1083-8.
22. Garite TJ, Freeman RK, Linzey EM, Braly PS, Dorchester WL. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol 1981;141:508-15.
23. Kari MA, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with human surfactant therapy: a randomized placebo-controlled multicenter study. Pediatrics 1994;93:730-6.
24. Shankaran S, Bauer CR, Bain R, et al. Relationship between antenatal steroid administration in Grade III and IV intracranial hemorrhage in low birth weight infants. Am J Obstet Gynecol 1995;173:305-12.
25. Stein HM, Oyama K, Martinez A, et al. Effects of corticosteroids in preterm sheep on adaptation and sympathoadrenal mechanisms at birth. Am J Physiol 1993;264:E763-9.
26. Moise AA, Wearden ME, Welty SE, Kozinetz CA, Hansen TN. Antenatal steroids reduce the need for blood pressure support in extremely premature infants. Pediatrics 1995;95:845-50.
27. Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 1988;64: 2366-71.
28. Andrews EB, White AD, Weinberg JM, Layne R, Long WA. Antenatal steroids and neonatal outcomes in infants receiving surfactants in the Exosurf Treatment IND [Abstract]. Pediatr Res 1992;31:241A.
29. Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993;168:508-13.
30. Ballard RA, Ballard PL. Lung maturation in prenatal preparation of the fetus. In: Reed GB, Claireaux AE, Cockburn F, eds. Diseases of the fetus and newborn, 2nd ed. London: Chapman and Hall, 1995:1337-43.
31. Ballard PL, Granberg JP, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56:1548-54.
32. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk of bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-10.
33. Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995;273:413-8.
34. National Institutes of Health Consensus Development Conference Statement. Am J Obstet Gynecol 1995;173:246-52.
35. Atkinson AM, Gaudier F, Cliver SP, et al. The interaction of the maternal corticosteroids and tocolytic treatment on morbidity and mortality rates in very low birth weight infants {Abstract}. Am J Obstet Gynecol 1994;170:386.
36. Ballard PL. Hormonal regulation of pulmonary surfactant. Endocrine Rev 1989;10:165-81.
37. Gonzales LW, Ballard PL, Ertsey R, Williams MC. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986;62:678-91.
38. Liggins GC, Schellenberg JC Manzai M, Kitterman JA, Lee CCH. Synergism of cortisol and thyrotropin releasing hormone on lung maturation in fetal sheep. J Appl Physiol 1988;65:1880-4.
39. Mashiach S, Barkai G, Sack J, et al. The effect of intraamniotic thyroxine administration on fetal lung maturity in man. J Perinatol Med 1979;7: 161-9.
40. Romaguera J, Zorilla C, de la Vega A, et al. Responsiveness of L-S ratio of the amniotic fluid to intraamniotic administration of thyroxine. Am Obstet Gynecol Scand 1990;69:119-22.
41. Ballard PL, Ballard RA, Creasy RK, et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Pediatr Res 1992;32:673-8.
42. Morales WJ, Diebel D, Lazar AJ, Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol 1986;154:591-5.
43. Ballard RA, Ballard PL, Creasy RK, et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 1992;339:510-5.
44. Knight DB, Liggins GC, Wealthall SR. A randomized controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Am J Obstet Gynecol 1994;171:11-6.
45. Crowther CA, Alfirevic Z. Antenatal thyrotropin-releasing hormone (TRH) prior to preterm delivery. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, eds. Pregnancy and childbirth module. Cochrane Database of Systematic Reviews: Review No. 2955, 26 April 1993. Published through Cochrane Updates on Disk, Oxford. Update Software, Spring 1993.
46. Crowther CA, Hiller JE, Haslam RR, Robinson JS, Group AS. Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet 1995;345:877-82.
47. Piecuch R, Ballard R, Leonard C, Behle M, Henning D. Neurodevelopmental outcome of preterm infants treated with antenatal thyrotropin releasing hormone (TRH) (abstract). Pediatr Res 1994;35:283A.